Leveraging Transparency Data to Enhance Commercial Targeting:
A Case Study in Chronic Obstructive Pulmonary Disease

Published January 2017   •  6 Pages
By augmenting traditional sales force targeting approaches with emerging transparency data, drug and device makers can gain a more comprehensive understanding of promotionally accessible prescribers and increase overall share of voice in high value accounts:

  • Insight into market-level promotional activity and competitive intensity
  • Perspective on physician-level access and receptiveness to personal promotion
  • Identification of brand coverage gaps and opportunities to increase share of voice

Read the full case study

    Name (required)

    Company (required)

    Email Address (required)